Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitor

The spiroindolones, a new class of antimalarial medicines discovered in a cellular screen, are rendered less active by mutations in a parasite P-type ATPase, PfATP4. We show here that S. cerevisiae also acquires mutations in a gene encoding a P-type ATPase (ScPMA1) after exposure to spiroindolones and that these mutations are sufficient for resistance. KAE609 resistance mutations in ScPMA1 do not confer resistance to unrelated antimicrobials, but do confer cross sensitivity to the alkyl-lysophospholipid edelfosine, which is known to displace ScPma1p from the plasma membrane. Using an in vitro cell-free assay, we demonstrate that KAE609 directly inhibits ScPma1p ATPase activity. KAE609 also increases cytoplasmic hydrogen ion concentrations in yeast cells. Computer docking into a ScPma1p homology model identifies a binding mode that supports genetic resistance determinants and in vitro experimental structure-activity relationships in both P. falciparum and S. cerevisiae. This model also suggests a shared binding site with the dihydroisoquinolones antimalarials. Our data support a model in which KAE609 exerts its antimalarial activity by directly interfering with P-type ATPase activity.

[1]  Richard A. Friesner,et al.  Flexible ligand docking with Glide. , 2007, Current protocols in bioinformatics.

[2]  G. Fink,et al.  Yeast plasma membrane ATPase is essential for growth and has homology with (Na+ + K+), K+- and Ca2+-ATPases , 1986, Nature.

[3]  Rodrigo Lopez,et al.  Clustal W and Clustal X version 2.0 , 2007, Bioinform..

[4]  L. Burdine,et al.  Target identification in chemical genetics: the (often) missing link. , 2004, Chemistry & biology.

[5]  S. Brul,et al.  In vivo measurement of cytosolic and mitochondrial pH using a pH-sensitive GFP derivative in Saccharomyces cerevisiae reveals a relation between intracellular pH and growth. , 2009, Microbiology.

[6]  Gero Miesenböck,et al.  Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins , 1998, Nature.

[7]  D. Gottschling,et al.  Mother-daughter asymmetry of pH underlies aging and rejuvenation in yeast , 2014, eLife.

[8]  G. van Gemert,et al.  The Spiroindolone Drug Candidate NITD609 Potently Inhibits Gametocytogenesis and Blocks Plasmodium falciparum Transmission to Anopheles Mosquito Vector , 2012, Antimicrobial Agents and Chemotherapy.

[9]  Robin Taylor,et al.  Organic Fluorine Hardly Ever Accepts Hydrogen Bonds , 1997 .

[10]  Baldur P Magnusson,et al.  A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers , 2014, Antimicrobial Agents and Chemotherapy.

[11]  V. Zaremberg,et al.  Disruption of lipid domain organization in monolayers of complex yeast lipid extracts induced by the lysophosphatidylcholine analogue edelfosine in vivo. , 2015, Chemistry and physics of lipids.

[12]  R. Friesner,et al.  Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .

[13]  P. Hergenrother,et al.  Transcript profiling and RNA interference as tools to identify small molecule mechanisms and therapeutic potential. , 2011, ACS chemical biology.

[14]  W. Kühlbrandt,et al.  Structure, Mechanism, and Regulation of the Neurospora Plasma Membrane H ؉ -atpase , 2022 .

[15]  Jan H. Jensen,et al.  PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. , 2011, Journal of chemical theory and computation.

[16]  K. Kirk,et al.  The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs , 2015, International journal for parasitology. Drugs and drug resistance.

[17]  Jeremy R. Greenwood,et al.  Epik: a software program for pKa prediction and protonation state generation for drug-like molecules , 2007, J. Comput. Aided Mol. Des..

[18]  Sol Katzman,et al.  Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae. , 2014, Molecular bioSystems.

[19]  A. Gammie,et al.  Rapid Identification of Chemoresistance Mechanisms Using Yeast DNA Mismatch Repair Mutants , 2015, G3: Genes, Genomes, Genetics.

[20]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[21]  Trixie Wagner,et al.  Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria , 2010, Journal of medicinal chemistry.

[22]  Timothy J. Hanly,et al.  Bacterial genome reduction using the progressive clustering of deletions via yeast sexual cycling , 2015, Genome research.

[23]  P. Nissen,et al.  Structures and characterization of digoxin- and bufalin-bound Na+,K+-ATPase compared with the ouabain-bound complex , 2015, Proceedings of the National Academy of Sciences.

[24]  Tatiana Popova,et al.  Supplementary Methods , 2012, Acta Neuropsychiatrica.

[25]  D. Perlin,et al.  The Plasma Membrane H+‐ATPase of Fungi , 1997 .

[26]  Philip E. Bourne,et al.  A Multidimensional Strategy to Detect Polypharmacological Targets in the Absence of Structural and Sequence Homology , 2010, PLoS Comput. Biol..

[27]  Jeffery B. Klauda,et al.  CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. , 2009, Biophysical journal.

[28]  J. Haber,et al.  Pleiotropic plasma membrane ATPase mutations of Saccharomyces cerevisiae , 1987, Molecular and cellular biology.

[29]  John A. Tallarico,et al.  Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin , 2012, Cell host & microbe.

[30]  T. Kardos,et al.  Surface-Active Fungicidal d-Peptide Inhibitors of the Plasma Membrane Proton Pump That Block Azole Resistance , 2005, Antimicrobial Agents and Chemotherapy.

[31]  David W. Gray,et al.  A novel multiple-stage antimalarial agent that inhibits protein synthesis , 2015, Nature.

[32]  Andrei L. Lomize,et al.  OPM: Orientations of Proteins in Membranes database , 2006, Bioinform..

[33]  John R. Walker,et al.  Identification of pathogen genomic variants through an integrated pipeline , 2014, BMC Bioinformatics.

[34]  D. Perlin,et al.  The plasma membrane H(+)-ATPase of fungi. A candidate drug target? , 1997, Annals of the New York Academy of Sciences.

[35]  C. McMaster,et al.  Cytotoxicity of an Anti-cancer Lysophospholipid through Selective Modification of Lipid Raft Composition* , 2005, Journal of Biological Chemistry.

[36]  Yo Suzuki,et al.  Cloning Should Be Simple: Escherichia coli DH5α-Mediated Assembly of Multiple DNA Fragments with Short End Homologies , 2015, PloS one.

[37]  Hongshen Ma,et al.  (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium , 2014, Proceedings of the National Academy of Sciences.

[38]  F. Blasco,et al.  Pharmacokinetic-Pharmacodynamic Analysis of Spiroindolone Analogs and KAE609 in a Murine Malaria Model , 2014, Antimicrobial Agents and Chemotherapy.

[39]  C. McMaster,et al.  Alteration of Plasma Membrane Organization by an Anticancer Lysophosphatidylcholine Analogue Induces Intracellular Acidification and Internalization of Plasma Membrane Transporters in Yeast* , 2013, The Journal of Biological Chemistry.

[40]  A. Mason,et al.  Exploring an antifungal target in the plasma membrane H(+)-ATPase of fungi. , 1997, Biochimica et biophysica acta.

[41]  F. Portillo,et al.  Growth control strength and active site of yeast plasma membrane ATPase studied by site-directed mutagenesis. , 1989, European journal of biochemistry.

[42]  Robert W. Sauerwein,et al.  Targeting Plasmodium PI(4)K to eliminate malaria , 2013, Nature.

[43]  R. Sikorski,et al.  A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. , 1989, Genetics.

[44]  Kiaran Kirk,et al.  Diverse chemotypes disrupt ion homeostasis in the malaria parasite , 2014, Molecular microbiology.

[45]  W. Kühlbrandt.  Biology, structure and mechanism of P-type ATPases , 2004, Nature Reviews Molecular Cell Biology.

[46]  Sandhya Kortagere,et al.  Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum , 2014, Nature Communications.

[47]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[48]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[49]  George M. Church,et al.  Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems , 2013, Nucleic acids research.

[50]  B. Honig,et al.  A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.

[51]  Thomas H Segall-Shapiro,et al.  Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome , 2010, Science.

[52]  J. Revuelta,et al.  Drug Uptake, Lipid Rafts, and Vesicle Trafficking Modulate Resistance to an Anticancer Lysophosphatidylcholine Analogue in Yeast* , 2013, The Journal of Biological Chemistry.

[53]  Elizabeth A. Winzeler,et al.  Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials , 2014, ACS chemical biology.

[54]  Baldur P Magnusson,et al.  Spiroindolone KAE609 for falciparum and vivax malaria. , 2014, The New England journal of medicine.

[55]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[56]  R. Schiestl,et al.  High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier , 1989, Current Genetics.

[57]  F. Supek,et al.  Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease , 2015, PLoS pathogens.

[58]  M. Cyert,et al.  Regulation of Cation Balance in Saccharomyces cerevisiae , 2013, Genetics.

[59]  Vincent Hernandez,et al.  An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site , 2007, Science.

[60]  Elizabeth A. Winzeler,et al.  Na+ Regulation in the Malaria Parasite Plasmodiumfalciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials , 2013, Cell host & microbe.

[61]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[62]  Lan V. Zhang,et al.  Knocking out multi-gene redundancies via cycles of sexual assortment and fluorescence selection , 2010, Nature Methods.

[63]  Edith D. Wong,et al.  Saccharomyces Genome Database: the genomics resource of budding yeast , 2011, Nucleic Acids Res..

[64]  Hinrich W. H. Göhlmann,et al.  A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis , 2005, Science.

[65]  Cathy H. Wu,et al.  The Universal Protein Resource (UniProt) , 2004, Nucleic Acids Res..

[66]  Stuart L Schreiber,et al.  The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods. , 2016, Cell chemical biology.

[67]  Bruce Russell,et al.  Spiroindolones, a Potent Compound Class for the Treatment of Malaria , 2010, Science.

[68]  Ge-Fei Hao,et al.  Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. , 2012, Journal of the American Chemical Society.

[69]  Norbert Perrimon,et al.  RNAi screening comes of age: improved techniques and complementary approaches , 2014, Nature Reviews Molecular Cell Biology.

[70]  T. H. Wood,et al.  Escherichia coli K-12 Mutants Resistant to Nalidixic Acid: Genetic Mapping and Dominance Studies , 1969, Journal of bacteriology.

[71]  Acknowledgements , 1992, Experimental Gerontology.